PROTAC CBP/EP300 degrader-1
PROTAC CBP/EP300 Degrader-5 is a CBP and EP300 PROTAC degrader. PROTAC CBP/EP300 Degrader-5 relies on the ubiquitin-proteasome pathway to preferentially induce ubiquitination and degradation of EP300 rather than CBP. PROTAC CBP/EP300 Degrader-5 induces G1 phase cell cycle arrest and triggers Apoptosis. PROTAC CBP/EP300 Degrader-5 is applicable to research related to EP300-dependent malignant tumors.
(Pink: EP300 and CBP ligand (HY-184454); Blue: Cereblon ligand (HY-41547); Black: linker (HY-140213)).
For research use only. We do not sell to patients.
- Formula: C46H50N10O9
- Molecular Weight:886.95
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
|
EP300 |
CBP |
PROTAC CBP/EP300 Degrader-5 (Compound 25a) (10 μM) inhibits EP300 enzyme activity by 25.1% in a cell-free biochemical assay[1].
PROTAC CBP/EP300 Degrader-5 engages cellular CRBN with an EC50 of 0.62 μM in HEK293T cells[1].
PROTAC CBP/EP300 Degrader-5 potently and preferentially degrades EP300 (90.8% maximal degradation) over CBP (59.6% maximal degradation) in REH B-ALL cells[1].
PROTAC CBP/EP300 Degrader-5 (5 μM) mediates EP300 degradation via the ubiquitin-proteasome pathway in REH B-ALL cells, as shown by concentration-dependent rescue of EP300 expression with MG132 (0.1-1 μM) co-treatment[1].
PROTAC CBP/EP300 Degrader-5 (1-5 μM; 75 h) causes a significant, dose-dependent reduction in REH B-ALL cell proliferation[1].
PROTAC CBP/EP300 Degrader-5 (5 μM; 24 h) induces apoptosis in REH B-ALL cells, as shown by a significant increase in caspase 3/7 activity[1].
PROTAC CBP/EP300 Degrader-5 (1-5 μM) causes G1 cell cycle arrest in REH B-ALL cells, as shown by significant, dose-dependent accumulation of G1-phase cells and reduction of S+G2/M-phase cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:REH B-ALL cells
-
Concentration:1-5 μM
-
Incubation Time:25 h, 50 h, 75 h
-
Result:Induced a significant, dose-dependent reduction in viable cell number over the 75 h assay period, with greater inhibition observed at the higher 5 μM concentration.
-
Cell Line:REH B-ALL cells
-
Concentration:1-5 μM
-
Incubation Time:24 h
-
Result:Increased caspase 3/7 activity significantly after treatment with 5 μM, indicating induction of apoptosis.
Chemical Information
-
Molecular Weight 886.95
-
Formula C46H50N10O9
-
SMILES
O=C([C@@H]1N(C(C2(C3=CC=C(OCC4=CN(CCOCCOCCNC5=CC=CC(C(N6C(CC7)C(NC7=O)=O)=O)=C5C6=O)N=N4)C=C3)CCCC2)=O)CCC1)NC8=CC=CC9=C8C=NN9
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)